Table 2. Summary of the animal studies relating to using herbal extracts in autistic-like rodents.
Induction of autistic-like model |
Herb and dosage (route of administration) |
Period of herbal treatment |
Main effects of herbal treatment* |
Ref. |
SC injection of VPA (400 mg/kg) to mouse pups on PND 14 |
Camellia sinensis at 75 and 300 mg/kg/day (PO) |
PND 13-40 |
↓ Hyperactivity and anxiety-like behavior ↑ Sensorimotor reflex ↑ Spatial memory ↓ Plasma levels of MDA ↓ Cerebellar abnormalities (structural damage of Purkinje cells) |
[27] |
IP injection of VPA (600 mg/kg) to pregnant rats on GD 12.5 |
Camellia sinensis at 300 mg/kg/day (PO) |
PND 15-34 |
↑ Cerebellar and cortical levels of GABA and taurine ↓ Cerebellar and cortical levels of glutamate ↑ Cortical levels of serine ↑ Brain levels of cholesterol, GSH, SOD, and CAT ↓ Brain levels of MAO, AChE, MDA, NO, TNF-α and IL-6 |
[28] |
IP injection of VPA (600 mg/kg) to pregnant rats on GD 12.5 |
Bacopa monniera at 300 mg/kg/day (PO) |
PND 21-35 |
↓ Hyperactivity and anxiety-like behavior ↑ Sensorimotor reflex ↑ Sociability ↓ Hippocampal levels of total nitrite ↑ Hippocampal levels of GSH and CAT ↓ Cerebellar abnormalities (low number and structural damage of Purkinje cells) |
[29] |
IP injection of VPA (600 mg/kg) to pregnant rats on GD 12.5 |
Bacopa monniera at 20, 40, and 80 mg/kg/day (PO) |
PND 23-43 |
↑ Sociability and social preference ↓ Anxiety-like and repetitive behaviors ↑ Learning and memory ↑ Motor coordination ↑ Hippocampal and prefrontal levels of GSH, SOD, CAT and IL-10 ↓ Hippocampal and prefrontal levels of MDA, IL-1β, IL-6 and TNF-α ↓ Hippocampal and prefrontal expression of AMPA receptor ↓ Hippocampal and prefrontal abnormalities (structural damage of neuronal cells) |
[30] |
IP injection of VPA (500 mg/kg) to pregnant rats on GD 13 |
Asparagus racemosus at 50, 100, and 200 mg/kg/day (PO) |
PND 21-35 |
↓ Plasma levels of nitrite ↑ Brain levels of GSH and CAT ↓ Brain levels of MAO-A and AchE |
[31] |
SC injection of VPA (300 mg/kg) to pregnant mice on GD 10 |
Korean red ginseng at 100 and 200 mg/kg/day (PO) |
PND 21-38 |
↑ Sociability and social preference ↓ Repetitive behavior and hyperactivity ↑ Spatial working memory ↓ Hypersensitivity to electric seizure |
[32] |
SC injection of VPA (400 mg/kg) to pregnant rats on GD 12 |
Korean red ginseng at 20, 50, 100, and 200 mg/kg/day (PO) |
GD 10-15 |
↑ Locomotor activity, sociability, and social preference ↓ Hypersensitivity to electric seizure ↓ Tail deformation (teratogenicity of VPA) |
[33] |
SC injection of VPA (400 mg/kg) to rat pups on PND 14 |
Oryza sativa at 50, 100, and 200 mg/kg/day (PO) |
PND 14-40 |
↑ Sensorimotor reflex ↓ Anxiety-like and social avoidance behaviors ↑ Spatial memory ↑ Cerebellar levels of CAT, SOD, and GSH ↓ Cerebellar levels of MDA ↓ Cerebellar abnormalities (low density of Purkinje cells) |
[34] |
SC injection of VPA (400 mg/kg) to rat pups on PND 14 |
Morus alba at 25, 50, and 100 mg/kg/day (PO) |
PND 14-40 |
↑ Sensorimotor reflex ↓ Social avoidance behavior ↑ Spatial memory ↓ Hippocampal levels of MDA ↑ Hippocampal levels of CAT and GPx ↓ Hippocampal abnormalities (low density of neuronal cells) |
[35] |
IP injection of VPA (600 mg/kg) to pregnant rats on GD 12.5 |
Prangos ferulacea (L.) at 100 and 200 mg/kg/day (IP) |
PND 30-58 |
↓ Hippocampal levels of MDA ↑ Hippocampal levels of GSH and CAT ↓ Hippocampal abnormalities (high percentage of neuronal death) |
[36] |
SC injection of VPA (600 mg/kg) to pregnant rats on GD 12.5 |
Passiflora incarnata at 30, 100, and 300 mg/kg in drinking water (PO) |
PND 35-81 |
↑ Sociability and social preference ↓ Anxiety-like and repetitive behaviors ↑ Recognition memory ↑ Serum levels of CAT, SOD, and TAC ↓ Serum levels of MDA ↓ Cerebral abnormalities (high number of damaged neurons in the PFC and hippocampal CA1 areas) |
[37] |
IG gavage of VPA (400 mg/kg) to mouse pups on PND 14-16 |
Ziziphus talanai (Blanco) Merr. at 300 and 400 mg/kg/day (PO) |
PND 14-16 |
↑ Locomotor behavior ↓ Cerebellar abnormalities (structural damage of Purkinje cells) |
[38] |
SC injection of VPA (400 mg/kg) to mouse pups on PND 14 |
Ginkgo biloba at 100 mg/kg/day (IP) |
PND 13-40 |
↓ Serum levels of IL-17 ↓ Brain levels of MDA and IL-6 ↑ Brain levels of GSH and TGF-β1 ↑ Cerebellar levels of MBP and serotonin ↓ Cerebellar abnormalities (low number of Purkinje cells) |
[39] |
ICV infusion of PPA (4 µl of a 0.26 M solution) to male rats for 7 days (not specified) |
Clitoria ternatea L. at 250 and 500 mg/kg/day (PO) |
Not specified (treatment lasted for 28 days) |
↑ Novel object recognition ↑ Learning and memory ↓ Brain levels of serotonin and glutamate |
[40] |
Relative to the autistic-like animals not given herbal treatment (↑, increase; ↓, decrease). Only statistically significant findings are mentioned. VPA, valproic acid; PPA, propionic acid; SC, subcutaneous; PO, per oral; PND, postnatal day; IP, intraperitoneal; GD, gestational day; IG, intragastric; ICV, intracerebroventricular.